Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

NUS Insider Trading

NU SKIN ENTERPRISES, INC. | Wholesale-Drugs, Proprietaries & Druggists' Sundries

Comprehensive Trading Performance Summary

The investment history of corporate insiders at NU SKIN ENTERPRISES, INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Wholesale-Drugs, Proprietaries & Druggists' Sundries sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-11-13 00:32 2025-11-11 Hatchett Steven Keith Officer - Chief Product Officer BUY $9.61 5,500 $52,855 167,565 +3.4%
2025-09-05 00:12 2025-09-04 Nathanson Laura Director SELL $12.22 6,489 $79,296 33,149 -16.4%
2025-09-05 00:10 2025-09-03 Clark Chayce David Officer - EVP and General Counsel SELL $11.97 20,000 $239,400 233,140 -7.9%
2025-08-30 00:19 2025-08-29 CAMPBELL DANIEL W Director SELL $12.11 32,437 $392,669 53,375 -37.8%
2025-06-04 00:24 2025-06-02 WOODBURY EDWINA D Director SELL $8.44 4,532 $38,250 42,947 -9.5%
2025-06-04 00:04 2025-06-02 Battle Emma S. Director SELL $8.44 4,532 $38,250 31,006 -12.8%
2025-05-29 01:26 2025-05-28 Hatchett Steven Keith Officer - Chief Product Officer BUY $7.54 6,500 $49,010 162,065 +4.2%
2025-02-25 00:39 2025-02-21 Battle Emma S. Director SELL $7.73 1,693 $13,087 17,530 -8.8%
2024-05-29 01:18 2024-05-28 LIPMAN ANDREW D Director SELL $13.33 2,000 $26,660 23,225 -7.9%
2024-05-03 23:31 2024-05-02 WOODBURY EDWINA D Director SELL $12.02 1,693 $20,350 18,095 -8.6%
2024-04-26 01:02 2024-04-25 LIPMAN ANDREW D Director SELL $12.34 2,000 $24,680 25,225 -7.3%
2024-03-26 01:27 2024-03-25 LIPMAN ANDREW D Director SELL $12.32 2,000 $24,640 27,225 -6.8%
2024-02-28 00:55 2024-02-26 LIPMAN ANDREW D Director SELL $12.46 2,000 $24,920 29,225 -6.4%
2024-01-26 02:29 2024-01-25 LIPMAN ANDREW D Director SELL $18.55 2,000 $37,100 31,225 -6.0%
2023-12-28 00:46 2023-12-26 LIPMAN ANDREW D Director SELL $19.39 2,000 $38,780 33,225 -5.7%
2023-11-29 00:56 2023-11-27 LIPMAN ANDREW D Director SELL $17.11 2,000 $34,220 35,225 -5.4%
2023-11-07 00:57 2023-11-03 LIPMAN ANDREW D Director SELL $17.68 15,400 $272,272 37,225 -29.3%
2023-10-27 00:13 2023-10-25 LIPMAN ANDREW D Director SELL $19.23 2,000 $38,460 52,625 -3.7%
2023-09-26 01:29 2023-09-25 LIPMAN ANDREW D Director SELL $23.02 2,000 $46,040 54,625 -3.5%
2023-08-29 00:04 2023-08-25 LIPMAN ANDREW D Director SELL $23.33 2,000 $46,660 56,625 -3.4%
2023-08-23 00:33 2023-08-21 Nathanson Laura Director SELL $24.12 6,068 $146,360 10,300 -37.1%
2023-08-08 23:33 2023-08-07 Battle Emma S. Director SELL $26.15 1,272 $33,263 7,619 -14.3%
2023-07-26 01:08 2023-07-25 LIPMAN ANDREW D Director SELL $28.99 2,000 $57,980 58,625 -3.3%
2023-06-27 01:42 2023-06-26 LIPMAN ANDREW D Director SELL $32.12 2,000 $64,240 60,625 -3.2%
2023-05-26 23:50 2023-05-25 LIPMAN ANDREW D Director SELL $34.28 2,000 $68,560 58,393 -3.3%
2023-05-10 01:23 2023-05-09 WOODBURY EDWINA D Director SELL $37.87 1,255 $47,527 15,469 -7.5%
2023-04-26 00:25 2023-04-25 LIPMAN ANDREW D Director SELL $40.75 2,000 $81,500 60,393 -3.2%
2023-03-28 01:42 2023-03-27 LIPMAN ANDREW D Director SELL $39.29 2,000 $78,580 62,393 -3.1%
2023-03-10 02:55 2023-03-09 Hatchett Steven Keith Officer - Chief Product Officer OPT+S $39.78 21,155 $841,546 58,368 0.0%
2023-03-04 02:34 2023-03-02 Lawrence Mark H Officer - Chief Financial Officer OPT+S $40.80 26,144 $1,066,675 57,146 0.0%
2023-03-04 02:32 2023-03-01 CHANG JOSEPH Y Officer - Chief Scientific Officer OPT+S $40.53 93,485 $3,788,779 21,234 0.0%
2023-03-01 03:46 2023-02-27 NAPIERSKI RYAN S Director, Officer - President and CEO OPT+S $41.07 31,513 $1,294,362 168,784 0.0%
2023-02-24 02:06 2023-02-22 Battle Emma S. Director SELL $41.70 987 $41,158 4,659 -17.5%
2023-02-24 02:00 2023-02-22 LIPMAN ANDREW D Director SELL $41.42 1,000 $41,420 64,393 -1.5%
2023-02-24 01:58 2023-02-23 Thomas James D Officer - Chief Accounting Officer SELL $41.12 2,829 $116,328 17,928 -13.6%
2023-01-24 02:58 2023-01-23 LIPMAN ANDREW D Director SELL $42.27 1,000 $42,270 65,393 -1.5%
2022-12-23 01:50 2022-12-22 LIPMAN ANDREW D Director SELL $40.75 1,000 $40,750 66,393 -1.5%
2022-11-29 00:48 2022-11-25 NAPIERSKI RYAN S Director, Officer - President and CEO OPT+S $38.45 25,000 $961,250 122,683 0.0%
2022-11-23 01:40 2022-11-22 LIPMAN ANDREW D Director SELL $38.16 1,000 $38,160 67,393 -1.5%
2022-10-25 00:25 2022-10-21 LIPMAN ANDREW D Director SELL $35.92 1,000 $35,920 68,393 -1.4%
2022-09-23 01:17 2022-09-22 LIPMAN ANDREW D Director SELL $36.67 1,000 $36,670 69,393 -1.4%
2022-09-09 00:11 2022-09-07 Thomas James D Officer - Chief Accounting Officer SELL $39.19 1,602 $62,782 12,722 -11.2%
2022-08-26 01:36 2022-08-25 NAPIERSKI RYAN S Director, Officer - President and CEO OPT+S $42.99 25,000 $1,074,865 122,683 0.0%
2022-08-23 01:42 2022-08-22 LIPMAN ANDREW D Director SELL $45.01 1,000 $45,010 70,393 -1.4%
2022-08-20 00:27 2022-08-18 Hatchett Steven Keith Officer - Chief Product Officer SELL $46.78 5,500 $257,290 49,431 -10.0%
2022-07-23 00:30 2022-07-22 LIPMAN ANDREW D Director SELL $43.00 1,000 $43,000 71,393 -1.4%
2022-06-24 01:20 2022-06-23 LUND STEVEN Director, Officer - Exec. Chairman of the Board SELL $45.18 17,129 $773,839 20,800 -45.2%
2022-06-23 01:36 2022-06-22 LIPMAN ANDREW D Director SELL $44.06 1,000 $44,060 72,393 -1.4%
2022-06-23 01:34 2022-06-17 LUND STEVEN Director, Officer - Exec. Chairman of the Board SELL $45.02 8,126 $365,820 22,975 -26.1%
2022-06-16 01:34 2022-06-13 LUND STEVEN Director, Officer - Exec. Chairman of the Board SELL $43.84 51,695 $2,266,329 27,000 -65.7%
SHOW ENTRIES

How to Interpret $NUS Trades

Not every insider transaction in NU SKIN ENTERPRISES, INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $NUS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for NUS

Insider activity data for NU SKIN ENTERPRISES, INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $NUS, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.